With the passage of the 2018 Agriculture Improvement Act (“2018 Farm Bill”), hemp and its extracts, derivatives and cannabinoids were removed from the shackles of the Controlled Substances Act on January 1, 2019, and consumer demand for cannabidiol (CBD) products is skyrocketing. However, the U.S. Food & Drug Administration’s (FDA’s) guidance position that CBD may not be marketed as a dietary supplement or food additive due to the investigation and subsequent approval of CBD as a drug is causing significant legal and regulatory confusion within States, while illicit and substandard manufacturers exploit this confusion. But rigorous regulatory frameworks of course do exist for the labeling, current good manufacturing practices, and marketing of dietary supplements and food, and entities engaged in these businesses in the U.S. are obligated to comply with those standards. This seminar will explore the impact of the 2018 Farm Bill, the Investigational New Drug preclusion within the Food, Drug & Cosmetic Act, isolate versus full-spectrum extract, the FDA’s authority and progress, and the manner in which Washington, Oregon, and certain other States are regulating CBD. We will also explore federal regulation surrounding the labeling, manufacturing, and marketing of CBD products being manufactured and sold in the U.S., including cosmetics and pet food.
BACK TO TOP
Daniel Shortt, Program Chair, is a corporate and regulatory attorney with Green Light Law Group based in Seattle, who works extensively with entrepreneurs in the cannabis industry. He advises clients on matters related to both hemp and marijuana, and frequently speaks on legal issues relating to cannabis across the country and abroad. He is quoted as an authority on cannabis law in dozens of publications.
Toby Astill, PhD, is PerkinElmer Inc’s Global Market Manager for Cannabis & Hemp. Dr. Astill has a Ph.D. in Chemistry and has spent the last 15 years working in Science, Technology and Business Roles for leading technology companies. He is now focused on driving PerkinElmer's global cannabis and hemp business; including but not limited to new product development, market and industry research.
Joy Beckerman is an internationally renowned hemp law & policy expert and educator who has been involved in the hemp industry for over a quarter century. She is the Founder/Principal at Hemp Ace International, a consulting, legal support, and expert witness firm serving the global community. She is also Director of Regulatory & Legal Affairs of Zilis, an international leader in hemp extract/CBD products.
Nathalie Bougenies, an attorney at Harris Bricken, focuses on the regulatory framework of hemp-derived CBD products. She is an authority on FDA enforcement, Food, Drug & Cosmetic Act and other laws and regulations surrounding hemp and Hemp CBD products. She also advises domestic and international clients on the sale, distribution, marketing, labeling, importation and exportation of these products.
Courtney N. Moran is the founding principal of EARTH Law LLC and a leading expert on hemp law. She champions legal policy for a sustainable industry, is a sought-after attorney, lobbyist, and speaker. She litigated the landmark case that established precedent for shipping hemp through the USPS and played a key role in drafting/negotiating the language included in the 2018 Farm Bill federally legalizing hemp.
Alicia Peterson is the Vice President and a Business Banker with First Citizens Bank. With over 15 years of banking experience, she works with a team of highly successful professionals in serving Business Owners with their banking needs. First Citizens Bank is the largest family controlled bank in the US, established in 1898 with offices in 21-states and over $34B in assets.
Ethan Russo, MD, the Founder and CEO of CReDO Science LLC, is a board-certified neurologist, psychopharmacology researcher, and author. He is the Founder and CEO of CannabisResearch.org. Previously, he was Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI) based in Prague, Czech Republic and Medical Director of PHYTECS.
Philip Snow is an attorney at the Kight Law Office, where he focuses on providing his clients solutions-based advice for the cannabis industry. After having spent the initial part of his career focusing on THC and marijuana, he recently shifted to hemp and other cannabinoids. He regularly advises on industry-specific compliance, FDA and FTC regulations, contract drafting and negotiating, as well as emerging cannabinoids.
Griffen Thorne is an attorney in the Los Angeles office of Harris Bricken, an international emerging markets law firm. As part of the corporate cannabis & hemp teams, he advises clients on obtaining licenses/permits, regulatory compliance, entity formation and structuring, mergers/acquisitions, corporate governance, contract drafting and negotiation, and obtaining/protecting intellectual property.
William Weller is a Business Banking Specialist with First Citizens Bank’s Kent Office. He helps clients to manage their business finances and banking solutions by cutting costs from the bottom line and bringing additional financial tools to the table that speed up cash-flow. He previously worked as a Branch Manager and Business Specialist at HomeStreet Bank.
This seminar is approved for the following credits:
This course has been approved for 4.5 hours of law and legal credit and 1.5 hours of other nexus CLE self-study credit by the Washington MCLE board. Go to our FAQ page for an explanation about Other CLE Credits. http://www.theseminargroup.net/customerservice.aspx#product-othercredit
This course has been approved by the Oregon State Bar for 6.0 general CLE credits.
The Seminar Group is a State Bar of California approved MCLE provider; therefore, this course is approved for 6.25 general CLE credits.
If you are purchasing only certain portions of the seminar then the full credit amount does not apply.
If you do not complete the full seminar you may not earn full credit. If you need assistance calculating your
credit please call our office at 206-463-4400 or 800-574-4852.
BACK TO TOP